These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34607088)

  • 1. Diverse predictors of treatment response to active medication and placebo in gambling disorder.
    Huneke NTM; Chamberlain SR; Baldwin DS; Grant JE
    J Psychiatr Res; 2021 Dec; 144():96-101. PubMed ID: 34607088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The placebo effect and its clinical associations in gambling disorder.
    Grant JE; Chamberlain SR
    Ann Clin Psychiatry; 2017 Aug; 29(3):167-172. PubMed ID: 28738096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
    Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial.
    van Die MD; Bone KM; Burger HG; Teede HJ
    BMC Med Res Methodol; 2009 Jun; 9():41. PubMed ID: 19549306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for posttraumatic stress disorder.
    Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
    Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation.
    Dobson ET; Strawn JR
    J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):686-693. PubMed ID: 27027330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Treatments for Disordered Gambling: A Meta-analysis.
    Goslar M; Leibetseder M; Muench HM; Hofmann SG; Laireiter AR
    J Gambl Stud; 2019 Jun; 35(2):415-445. PubMed ID: 30570700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders.
    Cohen D; Consoli A; Bodeau N; Purper-Ouakil D; Deniau E; Guile JM; Donnelly C
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):39-47. PubMed ID: 20166795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram.
    Stein DJ; Baldwin DS; Dolberg OT; Despiegel N; Bandelow B
    J Clin Psychiatry; 2006 Nov; 67(11):1741-6. PubMed ID: 17196054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of early dropout in treatment for gambling disorder: The role of personality disorders and clinical syndromes.
    Maniaci G; La Cascia C; Picone F; Lipari A; Cannizzaro C; La Barbera D
    Psychiatry Res; 2017 Nov; 257():540-545. PubMed ID: 28886591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of outcomes of psychological treatments for disordered gambling: A systematic review.
    Merkouris SS; Thomas SA; Browning CJ; Dowling NA
    Clin Psychol Rev; 2016 Aug; 48():7-31. PubMed ID: 27372437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of pharmacotherapy for pathological gambling: a chart review.
    Grant JE; Kim SW
    Ann Clin Psychiatry; 2002 Sep; 14(3):155-61. PubMed ID: 12585565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders.
    Ipser JC; Carey P; Dhansay Y; Fakier N; Seedat S; Stein DJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005473. PubMed ID: 17054260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current pharmacotherapy for gambling disorder: a systematic review.
    Kraus SW; Etuk R; Potenza MN
    Expert Opin Pharmacother; 2020 Feb; 21(3):287-296. PubMed ID: 31928246
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of tobacco use with gambling problem severity and gambling treatment outcome.
    Odlaug BL; Stinchfield R; Golberstein E; Grant JE
    Psychol Addict Behav; 2013 Sep; 27(3):696-704. PubMed ID: 22946857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers.
    Fong T; Kalechstein A; Bernhard B; Rosenthal R; Rugle L
    Pharmacol Biochem Behav; 2008 May; 89(3):298-303. PubMed ID: 18261787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials.
    Hofmann SG; Smits JA
    J Clin Psychiatry; 2008 Apr; 69(4):621-32. PubMed ID: 18363421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of psychiatric co-morbidity in treatment-seeking problem gamblers: A systematic review and meta-analysis.
    Dowling NA; Cowlishaw S; Jackson AC; Merkouris SS; Francis KL; Christensen DR
    Aust N Z J Psychiatry; 2015 Jun; 49(6):519-39. PubMed ID: 25735959
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.